RedHill Biopharma Ltd. (RDHL)

8.19
0.19 2.38
NASDAQ : Health Technology
Prev Close 8.00
Open 8.13
Day Low/High 8.05 / 8.25
52 Wk Low/High 4.30 / 11.25
Volume 74.07K
Avg Volume 85.00K
Exchange NASDAQ
Shares Outstanding 21.27M
Market Cap 164.34M
EPS -2.60
P/E Ratio 30.77
Div & Yield N.A. (N.A)

Latest News

Celgene Down After Pulling Plug on Crohn's Disease Drug Study -- Biotech Movers

Celgene Down After Pulling Plug on Crohn's Disease Drug Study -- Biotech Movers

The Summit, N.J.-based firm said Thursday that it was discontinuing the GED-0301 (mongersen) Phase 3 Revolve study in Crohn's disease and the extension trial.

TheStreet Quant Rating: D- (Sell)